Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 3Gynecologic 1Dermatologic 1

Conditions

Skin Neoplasms 2Carcinoma, Basal Cell 2Precancerous Conditions 1Non-melanoma Skin Cancer 1Melanoma 1Keratosis, Actinic 1Breast Neoplasms 1

Interventions

Cyclophosphamide 6fludarabine phosphate 5Peripheral Blood Stem Cell Transplantation 5Cyclosporine 4Antilymphocyte Serum 4Aminolevulinic Acid 4Whole-Body Irradiation 3Tacrolimus 3Mycophenolic Acid 3Methotrexate 3Etoposide 3Epoetin Alfa 3Darbepoetin alfa 3Busulfan 3Sirolimus 2Morphine 2Methylprednisolone 2Melphalan 2Filgrastim 2Biopsy 2tremelimumab 1tirbanibulin 1pyroxamide 1perillyl alcohol 1ferrous sulfate 1ferric gluconate 1arginine butyrate 1Triamcinolone 1Therapeutics 1Tetradecanoylphorbol Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precancerous Conditions × Eflornithine × Dermatologic × Clear all
NCT00021294 2018-09-11

Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis

University of Arizona

Phase 2 Completed
DermatologicOther neoplasm

Carcinoma, Basal Cell, Precancerous Conditions, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡